- Redfund
Capital’s 2018 portfolio consists of five companies; a total of 11
companies are in the pipeline at various due diligence stages
- New
partnership was announced at the end of November for the purpose of
developing water-soluble cannabis technologies
- During
2019, Redfund intends to maintain its CBD industry focus
The year of 2018 featured a number of important developments
for Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4), the first
medical cannabis incubator and accelerator financing medical cannabis, CBD and
hemp companies through a debt facility.
At the end of November, the company announced a key
partnership with Cannabis Strategic Ventures (OTC: NUGS) for the development of
water-soluble cannabis technologies to be used in the food and beverage
industry, via Redfund-owned Biolog Inc. (http://ibn.fm/qYedJ).
According to representatives of Redfund and Cannabis
Strategic Ventures, water-soluble cannabis technologies provide new
opportunities for growth in the world of CBD products. Current water-soluble
cannabis technologies come with specific limitations that stand in the way of
adoption. Hence, Redfund and Cannabis Strategic Ventures will seek alternatives
that enable the technology to push past original constraints for the purpose of
developing cannabis ingredients for ready addition to foods, beverages and cosmetic
products, to name a few.
Redfund has also partnered with Mary’s Wellness Ltd., a
marketer and distributor of cannabis-infused teas (http://ibn.fm/Kai3T), and it is
currently having active discussions with partners in the UK, Switzerland,
Colombia and Portugal to help launch Mary’s products.
Additionally, the company is funding Winterlife Inc. as the
latter launches a new CBD product line (http://ibn.fm/1Bb6a). Winterlife products are currently
available in over 600 dispensaries throughout the State of Washington, with
processing agreements in place with several other U.S. states.
In November, Redfund shared a comprehensive list of 2018
updates. According to the announcement, the core component of Redfund’s
business strategy through the year was to establish the foundations of a loan
portfolio that generates revenue with monthly interest income and that also
grows value for shareholders (http://ibn.fm/mb9Qz).
In 2018, the company extended funds for five signed
promissory notes. In addition, Redfund had 11 companies in the pipeline at
various stages of due diligence. As of November, the Redfund loan portfolio
consists of Winterlife, Mary’s Wellness, RxMM Health Care, Biominerales Pharma
Colombia and Biolog Inc.
Based on its strategy, Redfund aims to provide debt and
equity funding in the mid and later stages of the development of a target
company. The current focus is medical cannabis, hemp and CBD-related health
care/wellness companies.
Redfund also launched an array of innovative initiatives
throughout the year. First Euro Cannabis is one such initiative. A Redfund
subsidiary, First Euro Cannabis is the first incubator and accelerator in
Europe that finances medical cannabis, CBD and hemp companies. This subsidiary
is also expected to play a major role in the European distribution of
Winterlife products (http://ibn.fm/OUbWt).
In terms of future development, Redfund has made some
announcements about the growth anticipated in 2019.
Two of the companies in the Redfund portfolio are
investigating the process for filing to the Canadian Securities Exchange. By
the end of the first quarter of 2019, these companies anticipate becoming
stand-alone public entities.
“The Company vision is to have a portfolio of 20 companies
with $75 million injected through loans deployed to companies who have
commonalities of revenues, brand awareness, and a keen interest to go global
with their products… We are looking forward to our portfolio companies being
leaders in the public markets,” Redfund CEO Meris Kott said in a news release.
For more information, visit the company’s website at www.RedfundCapital.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment